
Bruck Kifle
Examiner (ID: 2332)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 1624, 1611, 1622 |
| Total Applications | 3434 |
| Issued Applications | 2601 |
| Pending Applications | 222 |
| Abandoned Applications | 651 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8630166
[patent_doc_number] => 08362238
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Method for refining of high purity of tacrolimus'
[patent_app_type] => utility
[patent_app_number] => 12/921820
[patent_app_country] => US
[patent_app_date] => 2009-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4098
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12921820
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921820 | Method for refining of high purity of tacrolimus | Feb 24, 2009 | Issued |
Array
(
[id] => 7555528
[patent_doc_number] => 08067429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Forms of rifaximin and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/393012
[patent_app_country] => US
[patent_app_date] => 2009-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 43
[patent_no_of_words] => 21913
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067429.pdf
[firstpage_image] =>[orig_patent_app_number] => 12393012
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/393012 | Forms of rifaximin and uses thereof | Feb 24, 2009 | Issued |
Array
(
[id] => 5539752
[patent_doc_number] => 20090221557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => '3-AMINOALKYL-1,4-DIAZEPAN-2-ONE MELANOCORTIN-5 RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/391720
[patent_app_country] => US
[patent_app_date] => 2009-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66322
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221557.pdf
[firstpage_image] =>[orig_patent_app_number] => 12391720
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/391720 | 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists | Feb 23, 2009 | Issued |
Array
(
[id] => 5404525
[patent_doc_number] => 20090239839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'RECEPTOR ANTAGONIST'
[patent_app_type] => utility
[patent_app_number] => 12/391520
[patent_app_country] => US
[patent_app_date] => 2009-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 67516
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239839.pdf
[firstpage_image] =>[orig_patent_app_number] => 12391520
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/391520 | RECEPTOR ANTAGONIST | Feb 23, 2009 | Abandoned |
Array
(
[id] => 6351894
[patent_doc_number] => 20100331317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'BENZODIAZEPINE COMPOUND AND PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/918226
[patent_app_country] => US
[patent_app_date] => 2009-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80310
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0331/20100331317.pdf
[firstpage_image] =>[orig_patent_app_number] => 12918226
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918226 | Benzodiazepine compound and pharmaceutical composition | Feb 19, 2009 | Issued |
Array
(
[id] => 5502785
[patent_doc_number] => 20090163473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => '(PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/389968
[patent_app_country] => US
[patent_app_date] => 2009-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7372
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163473.pdf
[firstpage_image] =>[orig_patent_app_number] => 12389968
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/389968 | (Pyrido/thieno)-[f]-oxazepine-5-one derivatives | Feb 19, 2009 | Issued |
Array
(
[id] => 102713
[patent_doc_number] => 07723341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Compounds for the treatment of inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 12/388835
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35816
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723341.pdf
[firstpage_image] =>[orig_patent_app_number] => 12388835
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/388835 | Compounds for the treatment of inflammatory diseases | Feb 18, 2009 | Issued |
Array
(
[id] => 5436244
[patent_doc_number] => 20090170831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/388944
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34915
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170831.pdf
[firstpage_image] =>[orig_patent_app_number] => 12388944
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/388944 | Substituted lactams as inhibitors of Aβ protein production | Feb 18, 2009 | Issued |
Array
(
[id] => 5422994
[patent_doc_number] => 20090149449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'PYRROLOBENZODIAZEPINE DERIVATIVES, COMPOSITIONS COMPRISING THE SAME AND METHODS RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 12/370856
[patent_app_country] => US
[patent_app_date] => 2009-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19676
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149449.pdf
[firstpage_image] =>[orig_patent_app_number] => 12370856
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/370856 | Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto | Feb 12, 2009 | Issued |
Array
(
[id] => 5977933
[patent_doc_number] => 20110071139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'Cycloalkyl Lactame Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1'
[patent_app_type] => utility
[patent_app_number] => 12/867374
[patent_app_country] => US
[patent_app_date] => 2009-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29890
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20110071139.pdf
[firstpage_image] =>[orig_patent_app_number] => 12867374
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867374 | Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 | Feb 12, 2009 | Issued |
Array
(
[id] => 5480944
[patent_doc_number] => 20090203901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Process for preparing pyrazole functionalized benzodiazepinones'
[patent_app_type] => utility
[patent_app_number] => 12/378363
[patent_app_country] => US
[patent_app_date] => 2009-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 21568
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203901.pdf
[firstpage_image] =>[orig_patent_app_number] => 12378363
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/378363 | Process for preparing pyrazole functionalized benzodiazepinones | Feb 11, 2009 | Abandoned |
Array
(
[id] => 54071
[patent_doc_number] => 07767663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-03
[patent_title] => 'Analogs of benzoquinone-containing ansamycins and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/369545
[patent_app_country] => US
[patent_app_date] => 2009-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 88
[patent_figures_cnt] => 91
[patent_no_of_words] => 38736
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/767/07767663.pdf
[firstpage_image] =>[orig_patent_app_number] => 12369545
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/369545 | Analogs of benzoquinone-containing ansamycins and methods of use thereof | Feb 10, 2009 | Issued |
Array
(
[id] => 5391277
[patent_doc_number] => 20090208590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/369549
[patent_app_country] => US
[patent_app_date] => 2009-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 89
[patent_figures_cnt] => 89
[patent_no_of_words] => 38735
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208590.pdf
[firstpage_image] =>[orig_patent_app_number] => 12369549
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/369549 | Analogs of benzoquinone-containing ansamycins and methods of use thereof | Feb 10, 2009 | Issued |
Array
(
[id] => 8701567
[patent_doc_number] => 08394789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-12
[patent_title] => '(Dihydro)pyrrolo[2,1-α]isoquinolines'
[patent_app_type] => utility
[patent_app_number] => 12/866468
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48439
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12866468
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866468 | (Dihydro)pyrrolo[2,1-α]isoquinolines | Feb 5, 2009 | Issued |
Array
(
[id] => 8043815
[patent_doc_number] => 20120071648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'METHOD FOR PRODUCING LACTAMATES BY WAY OF THIN FILM EVAPORATION'
[patent_app_type] => utility
[patent_app_number] => 12/865458
[patent_app_country] => US
[patent_app_date] => 2009-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4175
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071648.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865458
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865458 | Method for producing lactamates by way of thin film evaporation | Feb 4, 2009 | Issued |
Array
(
[id] => 6266624
[patent_doc_number] => 20100298269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'PRODRUGS OF CGRP RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/864120
[patent_app_country] => US
[patent_app_date] => 2009-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11822
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298269.pdf
[firstpage_image] =>[orig_patent_app_number] => 12864120
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864120 | Prodrugs of CGRP receptor antagonists | Feb 3, 2009 | Issued |
Array
(
[id] => 4624363
[patent_doc_number] => 08003659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-23
[patent_title] => 'Macrocyclic serine protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/365127
[patent_app_country] => US
[patent_app_date] => 2009-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76008
[patent_no_of_claims] => 189
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/003/08003659.pdf
[firstpage_image] =>[orig_patent_app_number] => 12365127
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/365127 | Macrocyclic serine protease inhibitors | Feb 2, 2009 | Issued |
Array
(
[id] => 6025883
[patent_doc_number] => 20110053873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'HSP90 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/865713
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 99052
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053873.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865713
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865713 | HSP90 INHIBITORS | Jan 29, 2009 | Abandoned |
Array
(
[id] => 132976
[patent_doc_number] => 07696209
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-13
[patent_title] => 'CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 12/363175
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36228
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/696/07696209.pdf
[firstpage_image] =>[orig_patent_app_number] => 12363175
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/363175 | CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | Jan 29, 2009 | Issued |
Array
(
[id] => 8630165
[patent_doc_number] => 08362237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Optical-isomer separating agent for chromatography and process for producing the same'
[patent_app_type] => utility
[patent_app_number] => 12/735516
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 90
[patent_no_of_words] => 17309
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12735516
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/735516 | Optical-isomer separating agent for chromatography and process for producing the same | Jan 29, 2009 | Issued |